RNase H2, mutated in Aicardi‐Goutières syndrome, promotes LINE‐1 retrotransposition
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Long INterspersed Element class 1 (LINE‐1) elements are a type of abundant retrotransposons active in mammalian genomes. An average human genome contains ~100 retrotransposition‐competent LINE‐1s, whose activity is influenced by the combined action of cellular repressors and activators. TREX1, SAMHD1 and ADAR1 are known LINE‐1 repressors and when mutated cause the autoinflammatory disorder Aicardi‐Goutières syndrome (AGS). Mutations in RNase H2 are the most common cause of AGS, and its activity was proposed to similarly control LINE‐1 retrotransposition. It has therefore been suggested that increased LINE‐1 activity may be the cause of aberrant innate immune activation in AGS. Here, we establish that, contrary to expectations, RNase H2 is required for efficient LINE‐1 retrotransposition. As RNase H1 overexpression partially rescues the defect in RNase H2 null cells, we propose a model in which RNase H2 degrades the LINE‐1 RNA after reverse transcription, allowing retrotransposition to be completed. This also explains how LINE‐1 elements can retrotranspose efficiently without their own RNase H activity. Our findings appear to be at odds with LINE‐1‐derived nucleic acids driving autoinflammation in AGS. Several mechanisms exist to restrict LINE‐1 retrotransposition, some of which involve TREX1, SAMHD1 or ADAR1, proteins mutated in Aicardi‐Goutières syndrome (AGS), a type I interferonopathy. Mutations in RNase H2 also cause AGS. However, RNase H2 activity promotes rather than restricts LINE‐1 mobilisation. In contrast to other Aicardi‐Goutières associated proteins that act to restrict LINE‐1 retrotranspostion, RNase H2 activity facilitates LINE‐1 mobilisation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · cited 1×
“:3) cells (Bunz et al , 1998; Dornan et al , 2004), a kind gift from K. Ball (Edinburgh), were maintained in modified McCoy’s 5A medium (Gibco; Cat no 26600-023) supplemented with 10% FBS, 50 U/ml penicillin and 50 l g/ml streptomycin.”
cGAS surveillance of micronuclei links genome instability to innate immunity
Mackenzie, K. J., Carroll, P., Martin, C.-A., Murina, O., Fluteau, A., Simpson, D. J., Olova, N., Sutcliffe, H., Rainger, J. K., Leitch, A., et al. (2017) · Nature · doi:10.1038/nature23449 · Cited by 1,752 · cited 1×
“Furthermore, we established a mechanism linking genome instability to inflammation, with micronuclei providing a source of cytoplasmic DNA able to activate cGAS, (Mackenzie et al , 2017), although the direct relevance of this to AGS remains to be determined.”
Self-citationTrex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280 · cited 7×
“…are expressed and highly active in the central nervous system (Muotri et al , 2005; Coufal et al , 2009) and strong experimental evidence suggests that TREX1, SAMHD1 and ADAR1 act as LINE-1 restriction factors (Stetson et al , 2008; Zhao et al , 2013; Orecchini et al , 2017; Thomas et al , 2017).”
InfluentialLuan, D. D., Korman, M. H., Jakubczak, J. L., & Eickbush, T. H. (1993) · Cell · doi:10.1016/0092-8674(93)90078-5 · Cited by 1,173
Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition
Feng, Q., Moran, J. V., Kazazian, H. H., & Boeke, J. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81997-2 · Cited by 1,139
Hot L1s account for the bulk of retrotransposition in the human population
Brouha, B., Schustak, J., Badge, R. M., Lutz-Prigge, S., Farley, A. H., Moran, J. V., & Kazazian, H. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831042100 · Cited by 1,073 · cited 1×
“An average human genome contains more than 500,000 L1 copies but only 80 – 100 can currently mobilise (Brouha et al , 2003; Beck et al , 2010); these are termed retrotrans-position-competent L1s or RC-L1s.”
High frequency retrotransposition in cultured mammalian cells
Moran, J. V., Holmes, S. E., Naas, T. P., DeBerardinis, R. J., Boeke, J. D., & Kazazian, H. H. (1996) · Cell · doi:10.1016/s0092-8674(00)81998-4 · Cited by 1,022
Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition
Muotri, A. R., Chu, V. T., Marchetto, M. C. N., Deng, W., Moran, J. V., & Gage, F. H. (2005) · Nature · doi:10.1038/nature03663 · Cited by 942 · cited 1×
“Notably, active LINE-1s are expressed and highly active in the central nervous system (Muotri et al , 2005; Coufal et al , 2009) and strong experimental evidence suggests that TREX1, SAMHD1 and ADAR1 act as LINE-1 restriction factors (Stetson et al , 2008; Zhao et al , 2013; Orecchini et al , 2017;…”
Aicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925 · cited 2×
“AGS is a type I interferonopathy where aberrant innate immune activation causes type I IFN production and clinical features reminiscent of a congenital viral infection of the brain (Crow & Manel, 2015).”
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
L1 retrotransposition in human neural progenitor cells
Coufal, N. G., Garcia-Perez, J. L., Peng, G. E., Yeo, G. W., Mu, Y., Lovci, M. T., Morell, M., O’Shea, K. S., Moran, J. V., & Gage, F. H. (2009) · Nature · doi:10.1038/nature08248 · Cited by 814 · cited 1×
“Notably, active LINE-1s are expressed and highly active in the central nervous system (Muotri et al , 2005; Coufal et al , 2009) and strong experimental evidence suggests that TREX1, SAMHD1 and ADAR1 act as LINE-1 restriction factors (Stetson et al , 2008; Zhao et al , 2013; Orecchini et al , 2017;…”
Self-citationLINE-1 Retrotransposition Activity in Human Genomes
Beck, C. R., Collier, P., Macfarlane, C., Malig, M., Kidd, J. M., Eichler, E. E., Badge, R. M., & Moran, J. V. (2010) · Cell · doi:10.1016/j.cell.2010.05.021 · Cited by 632
Active human retrotransposons: variation and disease
Hancks, D. C., & Kazazian, H. H. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.02.006 · Cited by 592 · cited 1×
“(Hancks & Kazazian, 2012; Garcia-Perez et al , 2016)].”
Origins and evolutionary relationships of retroviruses
Doolittle, R. F., Johnson, M. S., & McClure, M. A. (1989) · The Quarterly Review of Biology · doi:10.1086/416128 · Cited by 577
Human L1 element target‐primed reverse transcription in vitro
Cost, G. J., Feng, Q., Jacquier, A., & Boeke, J. D. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf592 · Cited by 519 · cited 13×
“The enzymatic activities of L1-ORF1p and L1-ORF2p are strictly required for LINE-1 retrotransposition (Moran et al , 1996).”
InfluentialMichelini, F., Pitchiaya, S., Vitelli, V., Sharma, S., Gioia, U., Pessina, F., Cabrini, M., Wang, Y., Capozzo, I., Iannelli, F., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3643 · Cited by 392
Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice
Cerritelli, S. M., Frolova, E. G., Feng, C., Grinberg, A., Love, P. E., & Crouch, R. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00088-1 · Cited by 358
RNase H2-Initiated Ribonucleotide Excision Repair
Sparks, J. L., Chon, H., Cerritelli, S. M., Kunkel, T. A., Johansson, E., Crouch, R. J., & Burgers, P. M. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.035 · Cited by 339 · cited 3×
“…the 5 0 -phosphodiester bond of ribonucleotides embedded in a DNA duplex, an activity required for the removal of misincorporated ribonucleotides (Nick McElhinny et al , 2010; Hiller et al , 2012; Reijns et al , 2012) in a process called Ribonucleotide Excision Repair or RER (Sparks et al , 2012).”
The enemy within: endogenous retroelements and autoimmune disease
Volkman, H. E., & Stetson, D. B. (2014) · Nature Immunology · doi:10.1038/ni.2872 · Cited by 333
Thomas, C. A., Tejwani, L., Trujillo, C. A., Negraes, P. D., Herai, R. H., Mesci, P., Macia, A., Crow, Y. J., & Muotri, A. R. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.07.009 · Cited by 330 · cited 3×
“…generated from human embryonic stem cells has strongly implicated accumulating LINE-1-derived single-stranded DNAs (ssDNAs) in type I IFN production and neurotoxicity (Thomas et al , 2017), consistent with a role for active LINE-1s in AGS pathophysiology (Garcia Perez & Alarcon-Riquelme, 2017).”
Ubiquitous L1 Mosaicism in Hippocampal Neurons
Upton, K. R., Gerhardt, D. J., Jesuadian, J. S., Richardson, S. R., Sánchez-Luque, F. J., Bodea, G. O., Ewing, A. D., Salvador-Palomeque, C., van der Knaap, M. S., Brennan, P. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.026 · Cited by 320 · cited 5×
“…the top strand of genomic DNA is cleaved, presumably by L1-ORF2p, releasing a 3 0 OH that is then used to prime second-strand cDNA synthesis, also presumed to be carried out by L1-ORF2p (Cost et al , 2002; Piskareva et al , 2003; Piskareva & Schmatchenko, 2006; reviewed in Richardson et al , 2015).”
InfluentialMutagenic Processing of Ribonucleotides in DNA by Yeast Topoisomerase I
Kim, N., Huang, S.-Y. N., Williams, J. S., Li, Y. C., Clark, A. B., Cho, J.-E., Kunkel, T. A., Pommier, Y., & Jinks-Robertson, S. (2011) · Science · doi:10.1126/science.1205016 · Cited by 291 · cited 2×
“These mutations are most likely to occur at tandem dinucleotide repeats, particularly CA:TG and GA:TC (Clark et al , 2011; Kim et al , 2011, 2013; Potenski et al , 2014).”
Ribonuclease H2 mutations induce a cGAS/STING‐dependent innate immune response
Mackenzie, K. J., Carroll, P., Lettice, L., Tarnauskaitė, Ž., Reddy, K., Dix, F., Revuelta, A., Abbondati, E., Rigby, R. E., Rabe, B., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593339 · Cited by 248
Self-citationMammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity
Hiller, B., Achleitner, M., Glage, S., Naumann, R., Behrendt, R., & Roers, A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120876 · Cited by 245 · cited 2×
“…of genomic DNA from KO clones after RNase H2 treatment and alkaline gel electrophoresis indicated the presence of large numbers of embedded ribonucleotides in KO clones (Fig 1C), a well-known consequence of RNase H2 deficiency (Nick McElhinny et al , 2010; Hiller et al , 2012; Reijns et al , 2012).”
Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy
Bartsch, K., Knittler, K., Borowski, C., Rudnik, S., Damme, M., Aden, K., Spehlmann, M. E., Frey, N., Saftig, P., Chalaris, A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx283 · Cited by 196 · cited 1×
“Furthermore, our findings are consistent with a recent report that also found RNase H2 to be required for retrotransposition (Bartsch et al , 2017).”
Modulation of LINE-1 and Alu/SVA Retrotransposition by Aicardi-Goutières Syndrome-Related SAMHD1
Zhao, K., Du, J., Han, X., Goodier, J. L., Li, P., Zhou, X., Wei, W., Evans, S. L., Li, L., Zhang, W., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.019 · Cited by 194
PCNA directs type 2 RNase H activity on DNA replication and repair substrates
Bubeck, D., Reijns, M. A. M., Graham, S. C., Astell, K. R., Jones, E. Y., & Jackson, A. P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq980 · Cited by 144
Self-citationCharacterization of L1 retrotransposition with high-throughput dual-luciferase assays
Xie, Y., Rosser, J. M., Thompson, T. L., Boeke, J. D., & An, W. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1076 · Cited by 98
Cited by
Molecular mechanisms and cellular functions of cGAS–STING signalling
Hopfner, K.-P., & Hornung, V. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0244-x · Cited by 2,052
Transposable Elements, Inflammation, and Neurological Disease
Saleh, A., Macia, A., & Muotri, A. R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00894 · Cited by 149
“The complete mechanism of second DNA strand cleavage and subsequent cDNA synthesis is unknown, but recent studies have suggested that RNase H2 is required to degrade the RNA:cDNA hybrid generated during this step (39).”
BackgroundCell fitness screens reveal a conflict between LINE-1 retrotransposition and DNA replication
Ardeljan, D., Steranka, J. P., Liu, C., Li, Z., Taylor, M. S., Payer, L. M., Gorbounov, M., Sarnecki, J. S., Deshpande, V., Hruban, R. H., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0372-1 · Cited by 135
DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes
Giordano, A. M. S., Luciani, M., Gatto, F., Abou Alezz, M., Beghè, C., Della Volpe, L., Migliara, A., Valsoni, S., Genua, M., Dzieciatkowska, M., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20211121 · Cited by 76
Self-citationRepetitive elements in aging and neurodegeneration
Copley, K. E., & Shorter, J. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.02.008 · Cited by 70
“In sharp contrast to other AGS-relevant proteins, RNaseH2A promotes L1 retrotransposition in human cell lines, perhaps by facilitating a step in target-primed reverse transcription [105].”
BackgroundResult
Metadata
- Authors
- Benitez‐Guijarro, M., Lopez‐Ruiz, C., Tarnauskaitė, Ž., Murina, O., Mian Mohammad, M., Williams, T. C., Fluteau, A., Sanchez, L., Vilar‐Astasio, R., Garcia‐Canadas, M., Cano, D., Kempen, M. H., Sanchez‐Pozo, A., Heras, S. R., Jackson, A. P., Reijns, M. A., & Garcia‐Perez, J. L.
- Venue
- The EMBO Journal
- Published
- 2018-06-29
- Volume
- 37
- Issue
- 15
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2811010473
- Cited by
- 79
- References
- 28
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.